These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29506689)

  • 1. Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na
    Calloe K; Broendberg AK; Christensen AH; Pedersen LN; Olesen MS; de Los Angeles Tejada M; Friis S; Thomsen MB; Bundgaard H; Jensen HK
    Int J Cardiol; 2018 Apr; 257():160-167. PubMed ID: 29506689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G213D variant in Nav1.5 alters sodium current and causes an arrhythmogenic phenotype resulting in a multifocal ectopic Purkinje-related premature contraction phenotype in human-induced pluripotent stem cell-derived cardiomyocytes.
    Calloe K; Geryk M; Freude K; Treat JA; Vold VA; Frederiksen HRS; Broendberg AK; Frederiksen TC; Jensen HK; Cordeiro JM
    Europace; 2022 Dec; 24(12):2015-2027. PubMed ID: 35726875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation.
    Lieve KV; Verkerk AO; Podliesna S; van der Werf C; Tanck MW; Hofman N; van Bergen PF; Beekman L; Bezzina CR; Wilde AAM; Lodder EM
    Int J Cardiol; 2017 Jun; 236():187-193. PubMed ID: 28262340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy.
    Mann SA; Castro ML; Ohanian M; Guo G; Zodgekar P; Sheu A; Stockhammer K; Thompson T; Playford D; Subbiah R; Kuchar D; Aggarwal A; Vandenberg JI; Fatkin D
    J Am Coll Cardiol; 2012 Oct; 60(16):1566-73. PubMed ID: 22999724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
    Laurent G; Saal S; Amarouch MY; Béziau DM; Marsman RF; Faivre L; Barc J; Dina C; Bertaux G; Barthez O; Thauvin-Robinet C; Charron P; Fressart V; Maltret A; Villain E; Baron E; Mérot J; Turpault R; Coudière Y; Charpentier F; Schott JJ; Loussouarn G; Wilde AA; Wolf JE; Baró I; Kyndt F; Probst V
    J Am Coll Cardiol; 2012 Jul; 60(2):144-56. PubMed ID: 22766342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
    Beckermann TM; McLeod K; Murday V; Potet F; George AL
    Heart Rhythm; 2014 Aug; 11(8):1446-53. PubMed ID: 24815523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report.
    Zakrzewska-Koperska J; Franaszczyk M; Bilińska Z; Truszkowska G; Karczmarz M; Szumowski Ł; Zieliński T; Płoski R; Bilińska M
    BMC Med Genet; 2018 Jun; 19(1):94. PubMed ID: 29871609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gain-of-function mutation in SCN5A responsible for multifocal ectopic Purkinje-related premature contractions.
    Doisne N; Waldmann V; Redheuil A; Waintraub X; Fressart V; Ader F; Fossé L; Hidden-Lucet F; Gandjbakhch E; Neyroud N
    Hum Mutat; 2020 Apr; 41(4):850-859. PubMed ID: 31930659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dilated cardiomyopathy caused by p.E446K mutation in SCN5A gene].
    Zakliaz'minskaia EV; Chapurnykh AV; Voronina TS; Van EIu; Shestak AG; Saber S; Dzemeshkevich SL
    Kardiologiia; 2014; 54(3):92-6. PubMed ID: 25102755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants in the SCN5A Promoter Associated With Various Arrhythmia Phenotypes.
    Yagihara N; Watanabe H; Barnett P; Duboscq-Bidot L; Thomas AC; Yang P; Ohno S; Hasegawa K; Kuwano R; Chatel S; Redon R; Schott JJ; Probst V; Koopmann TT; Bezzina CR; Wilde AA; Nakano Y; Aiba T; Miyamoto Y; Kamakura S; Darbar D; Donahue BS; Shigemizu D; Tanaka T; Tsunoda T; Suda M; Sato A; Minamino T; Endo N; Shimizu W; Horie M; Roden DM; Makita N
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27625342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype.
    Gosselin-Badaroudine P; Keller DI; Huang H; Pouliot V; Chatelier A; Osswald S; Brink M; Chahine M
    PLoS One; 2012; 7(5):e38331. PubMed ID: 22675453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.
    Watanabe H; Yang T; Stroud DM; Lowe JS; Harris L; Atack TC; Wang DW; Hipkens SB; Leake B; Hall L; Kupershmidt S; Chopra N; Magnuson MA; Tanabe N; Knollmann BC; George AL; Roden DM
    Circulation; 2011 Aug; 124(9):1001-11. PubMed ID: 21824921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A truncating SCN5A mutation combined with genetic variability causes sick sinus syndrome and early atrial fibrillation.
    Ziyadeh-Isleem A; Clatot J; Duchatelet S; Gandjbakhch E; Denjoy I; Hidden-Lucet F; Hatem S; Deschênes I; Coulombe A; Neyroud N; Guicheney P
    Heart Rhythm; 2014 Jun; 11(6):1015-1023. PubMed ID: 24582607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.
    Swan H; Amarouch MY; Leinonen J; Marjamaa A; Kucera JP; Laitinen-Forsblom PJ; Lahtinen AM; Palotie A; Kontula K; Toivonen L; Abriel H; Widen E
    Circ Cardiovasc Genet; 2014 Dec; 7(6):771-81. PubMed ID: 25210054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.
    McNair WP; Sinagra G; Taylor MR; Di Lenarda A; Ferguson DA; Salcedo EE; Slavov D; Zhu X; Caldwell JH; Mestroni L;
    J Am Coll Cardiol; 2011 May; 57(21):2160-8. PubMed ID: 21596231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characterisation of a novel
    Kean AC; Helm BM; Vatta M; Ayers MD; Parent JJ; Darragh RK
    Cardiol Young; 2019 Oct; 29(10):1257-1263. PubMed ID: 31477192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.
    Olson TM; Michels VV; Ballew JD; Reyna SP; Karst ML; Herron KJ; Horton SC; Rodeheffer RJ; Anderson JL
    JAMA; 2005 Jan; 293(4):447-54. PubMed ID: 15671429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmic Phenotypes Are a Defining Feature of Dilated Cardiomyopathy-Associated
    Peters S; Thompson BA; Perrin M; James P; Zentner D; Kalman JM; Vandenberg JI; Fatkin D
    Circ Genom Precis Med; 2022 Feb; 15(1):e003432. PubMed ID: 34949099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.